{
  "retracted": false,
  "timestamp": 1568246400000,
  "updates": [
    {
      "timestamp": 1581433830715,
      "identifier": {
        "doi": "10.1182/blood.2019002741"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2018-11-886457"
  },
  "publisher": "American Society of Hematology",
  "title": "Martin P, Bartlett NL, Blum KA, et al. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. Blood. 2019;133(11):1201-1204."
}
